retatrutide triple agonist clinical trials Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Reta clinical trial data &

So many women say, I hate waking up soaked, but I have a family history of breast cancer and was told I cant use hormone therapy. The fear surrounding HRT dates back to 2002, when findings from the Womens Health Initiative (WHI), a long-term national health study, linked HRT with an increased risk of breast cancer and heart disease

Systemic acetyl-L carnitine eliminates sensory neuronal loss after peripheral axotomy: a new clinical approach in the management of peripheral nerve trauma

Vivani envisions patients would initially use it as a maintenance treatment rather than a therapy people take when they start GLP-1s

Two formulas, one powerful result mix the white brightening capsule with the pink moisturizing base for a fresh, potent brightening cream every time